Comparison Capricor vs. ANP, page-18

Indirect or not, as long as their drug is addressing the symptoms of the disease and improves patient quality of life better than standard of care, then you have a marketable product. That's like saying panadol isn't a marketable drug because it addresses the symptoms of a headache and not the cause. I don't know enough about the industry or the other drugs commercially available or in development to comment with any authority, but from what others have told me there are not many options available.

I agree with her that it would be better if the control group was of this era and followed the test group throughout the study duration. That will come in later clinical trials, I imagine.